ADAGENE INC has a total of 77 patent applications. It decreased the IP activity by 10.0%. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are SEA LANE BIOTECHNOLOGIES LLC, JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO LTD and I2 PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 14 | |
#2 | Canada | 9 | |
#3 | EPO (European Patent Office) | 9 | |
#4 | United States | 8 | |
#5 | Australia | 7 | |
#6 | China | 7 | |
#7 | Republic of Korea | 6 | |
#8 | Singapore | 6 | |
#9 | Brazil | 5 | |
#10 | Israel | 5 | |
#11 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Combinatorial chemistry | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Du Fangyong | 66 |
#2 | Luo Peter Peizhi | 64 |
#3 | Li Yan | 32 |
#4 | Liu Guizhong | 32 |
#5 | Chen Jun | 11 |
#6 | She Xiaohong | 11 |
#7 | Cheung Peter | 11 |
#8 | Pan Zhongzong | 9 |
#9 | Peter Peizhi Luo | 5 |
#10 | Fangyong Du | 5 |
Publication | Filing date | Title |
---|---|---|
WO2020244574A1 | Anti-cd137l antibodies and methods of using same | |
US2021122824A1 | Anti-pd-l1 antibodies and use thereof | |
WO2019148445A1 | Precision/context-dependent activatable antibodies, and methods of making and using the same | |
WO2019148444A1 | Anti-ctla4 antibodies and methods of making and using the same | |
WO2019104716A1 | Methods for using cd137 ligand as biomarker for treatment with anti-cd137 antibody | |
AU2017428934A1 | Dynamic human antibody light chain libraries | |
WO2019036855A1 | Anti-cd137 molecules and use thereof | |
EP3673101A1 | Dynamic human heavy chain antibody libraries | |
EP3234147A1 | Methods and systems for autoinduction of protein expression | |
CN105247050A | An integrated system for library construction, affinity binder screening and expression thereof |